Χώρα: Ηνωμένο Βασίλειο
Γλώσσα: Αγγλικά
Πηγή: MHRA (Medicines & Healthcare Products Regulatory Agency)
Cefalexin
Actavis UK Ltd
J01DB01
Cefalexin
250mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 05010201
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. • Keep this leaflet.You may need to read it again. • If you have any further questions, ask your doctor, pharmacist or dentist (if the medicine has been prescribed by your dentist). • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, pharmacist or dentist (if the medicine has been prescribed by your dentist). IN THIS LEAFLET: 1. WHAT CEFALEXIN TABLETS ARE AND WHAT THEY ARE USED FOR 2. BEFORE YOU TAKE CEFALEXIN TABLETS 3. HOW TO TAKE CEFALEXIN TABLETS 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE CEFALEXIN TABLETS 6. FURTHER INFORMATION 1 . WHAT CEFALEXIN TABLETS ARE AND WHAT THEY ARE USED FOR The name of your medicine is Cefalexin Tablets. This medicine belongs to a family of medicines called antibiotics. Antibiotics are used to kill the bacteria or “germs” which cause infections. Your doctor, or dentist, will have prescribed this medicine for treating an infection. Cefalexin Tablets are used for treating a variety of infections including chest (respiratory tract), urinary tract, skin and soft tissues, ear, and other infections. 2. BEFORE YOU TAKE CEFALEXIN TABLETS DO NOT TAKE THIS MEDICINE BEFORE TELLING YOUR DOCTOR IF: • You are allergic to cefalexin or other antibiotics and medicines. • You are allergic to any of the other ingredients in this medicine. TAKE SPECIAL CARE WITH CEFALEXIN TABLETS: • You are pregnant or breast-feeding. Your doctor will decide whether it is safe for you to take this medicine while you are pregnant or breast-feeding. • You have problems with your kidneys. • You test your urine for glucose using a method which is not based on glucose oxidation reactions as this medicine might give a false positive result. • You are taking oral contraceptives. Cefalexin may reduce the efficacy of or Διαβάστε το πλήρες έγγραφο
OBJECT 1 CEFALEXIN TABLETS BP 250MG Summary of Product Characteristics Updated 01-Nov-2019 | Sandoz Limited • 1. Name of the medicinal product • 2. Qualitative and quantitative composition • 3. Pharmaceutical form • 4. Clinical particulars • 4.1 Therapeutic indications • 4.2 Posology and method of administration • 4.3 Contraindications • 4.4 Special warnings and precautions for use • 4.5 Interaction with other medicinal products and other forms of interaction • 4.6 Fertility, pregnancy and lactation • 4.7 Effects on ability to drive and use machines • 4.8 Undesirable effects • 4.9 Overdose • 5. Pharmacological properties • 5.1 Pharmacodynamic properties • 5.2 Pharmacokinetic properties • 5.3 Preclinical safety data • 6. Pharmaceutical particulars • 6.1 List of excipients • 6.2 Incompatibilities • 6.3 Shelf life • 6.4 Special precautions for storage • 6.5 Nature and contents of container • 6.6 Special precautions for disposal and other handling • 7. Marketing authorisation holder • 8. Marketing authorisation number(s) • 9. Date of first authorisation/renewal of the authorisation • 10. Date of revision of the text 1. Name of the medicinal product Cefalexin tablets BP 250mg 2. Qualitative and quantitative composition Each tablet contains Cefalexin BP equivalent to 250 mg anhydrous cefalexin. Excipient with known effect: Each tablet contains 67.5 mg lactose. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Film-coated tablets. Round, biconvex, white to yellowish. Scored on one side, with “CX” above the score and “250” below the score. Odour - slightly peppermint to characteristic of the active ingredient. 4. Clinical particulars 4.1 Therapeutic indications Cefalexin is indicated for the treatment of respiratory tract infections (R.T.I's), urinary tract infections (U.T.I's), skin and soft tissue infections, otitis media and other infections due to sensitive organisms. 4.2 Posology and method of administration Posology _Adults_ The Διαβάστε το πλήρες έγγραφο